Foam during reconstitution does not affect the potency of botulinum toxin type A

Dermatologic Surgery

Volumn 29, Issue 5, 2003, Pages 530-532

  De Almeida, Ada Regina Trindade ^a,b   Kadunc, Bogdana Victoria ^a   Di Chiacchio, Nilton ^a   Neto, Dalva Regina ^a   Carruthers, Alastair ^b   Carruthers, Jean ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENATURATION; DRUG EFFECT; DRUG MIXTURE; DRUG POTENCY; DRUG STABILITY; FACE WRINKLING; FEMALE; FOAM; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MUSCLE RELAXATION; PARALYSIS; PHOTOGRAPHY; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SKIN DISEASE;

ADULT; BOTULINUM TOXIN TYPE A; DRUG COMPOUNDING; DRUG STABILITY; FEMALE; HUMANS; MIDDLE AGED; NEUROMUSCULAR AGENTS;

EID: 0037948963     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29125.x     Document Type: Article

References (19)

1. Brin MF. Botulinum toxin therapy: basic science and overview of other therapeutic applications. In: Blitzer A, Binder WJ, Boyd B, Carruthers A, eds. Management of Facial Lines and Wrinkles. Philadelphia: Lippincott Williams & Wilkins, 2000: 279-302.
2. Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 2001;20:71-84.
3. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000;43:249-59.
4. Carter SR, Seiff SR. Cosmetic botulinum toxin injections. Int Ophthalmol Clin 1997;37:69-79.
5. Fagien S, Brandt FS. Primary and adjunctive use of botulinum toxin type A (Botox) in facial aesthetic surgery: beyond glabella. Clin Plast Surg 2001;28:127-48.
6. Carruthers A, Carruthers J. Botulinum toxin type A in the treatment of hyperfunctional facial lines and cosmetic disorders. In: Brin MF, Hallet M, Jankovic J, eds. Scientific and Therapeutic Aspects of Botulinum Toxin. Philadelphia: Lippincott Williams & Wilkins, 2002;27:287-93.
7. Product literature (package insert) on Botox. Irvine, CA: Allergan, Inc., April 2002.
8. Sommer B, Sattler G. Fundamental principles: product information. In: Sommer B, Sattler G, eds. Botulinum Toxin in Aesthetic Medicine. Berlin-Vienna: Blackwell Science 2001:16-9.
9. Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotoxin. Adv Dermatol 1997;12:325-48.
10. Alam M, Dover JS, Arndt KA. Pain associated with injection of BTX-A: reconstituted using isotonic sodium chloride with and without preservative: a double blind, randomized, controlled trial. Arch Dermatol 2002;138:510-4.
11. Klein A. Dilution and storage of botulinum toxin. Dermatol Surg 1998;24:1179-80.
12. Garcia A, Fulton JE. Cosmetic denervation of the muscles of facial expression with botulinum toxin: a dose-response study. Dermatol Surg 1996;22:39-43.
13. Gassner HG, Sherris DA. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study. Mayo Clin Proc 2000;75:701-4.
14. Gartlan MG, Hoffman HT. Crystalline preparation of botulinum toxin type A (BTX): degradation in potency with storage. Otolaryngol Head Neck Surg 1993;108:135-40.
15. Sloop RR, Cole BA, Escutin RO. Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use. Neurology 1997;48: 249-53.
16. Hankins CL, Strimling R, Rogers GS. Botulinum A toxin for glabellar wrinkles: dose and response. Dermatol Surg 1998;24:1181-3.
17. Fulton JE. Botulinum toxin: the Newport Beach experience. Dermatol Surg 1998;24:1219-24.
18. Aoki RK, Brin ME Botulinum toxin commercial efficacy, safety and duration of action comparison. In: Hexsel D, Almeida ART. Cosmetic Use of Botulinum Toxin. Porto Alegre, Brazil: AGE 2002;12:58-74.
19. Flynn TC, Carruthers JA, Carruthers JA. Botulinum A toxin treatment of the lower eyelid improves infraorbital rhytidesand widens the eye. Dermatol Surg 2001;27:703-8.